症状性正常血流低跨瓣压差重度主动脉瓣狭窄的干预与保守治疗比较
本研究在2012至2015年连续纳入主动脉瓣面积≤1.0 cm2、平均跨瓣压差<40 mm Hg、每搏输出量指数>35 ml/m2且有症状的成人患者,比较干预(SAVR或TAVR)与保守治疗的生存差异。平均随访652天后,保守治疗、TAVR和SAVR患者总死亡率分别为28%、10%和12%(p<0.001),TAVR较保守治疗生存改善(HR 0.49)。作者认为此类患者可能从干预中获益。
要点
- 主动脉瓣面积≤1.0 cm2、平均压差<40 mm Hg且每搏输出量指数>35 ml/m2的症状性患者占34%。
- 平均随访652天,保守治疗、TAVR和SAVR总死亡率分别为28%、10%和12%。
- 倾向评分匹配后保守治疗死亡25/94(28%)vs TAVR死亡10/94(12%)(p=0.016)。
核心结论
- 主动脉瓣面积≤1.0 cm2、正常血流、低跨瓣压差的症状性患者可能从干预中获益,而非保守治疗。
研究设计与样本
- 在Tel-Aviv医学中心2012至2015年连续纳入超声心动图检查的成人患者,主动脉瓣面积≤1.0 cm2、平均跨瓣压差<40 mm Hg、每搏输出量指数>35 ml/m2且有症状者纳入研究;干预组在超声检查后6个月内行SAVR或TAVR,其余保守治疗;终点为全因死亡和心源性死亡。
诊断标准与关键数值
- 研究纳入标准为主动脉瓣面积≤1.0 cm2、平均跨瓣压差<40 mm Hg、每搏输出量指数>35 ml/m2且有症状;在1358例主动脉瓣面积≤1.0 cm2且有症状的患者中,34%为正常血流低跨瓣压差,303例纳入研究。
临床应用与阅片要点
- 作者认为,主动脉瓣面积≤1.0 cm2、正常血流、低跨瓣压差的症状性患者可能从干预中获益,而非保守治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to describe patients with severe symptomatic aortic stenosis with normal flow and low gradients and determine whether they benefit from intervention.
BACKGROUND: Severe symptomatic aortic stenosis is a progressive disease with high mortality. Although surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR) are indicated for patients with high gradients (>40 mm Hg) or low gradients due to low flow, the approach for patients with normal flow and low gradients is poorly defined.
METHODS: Consecutive adult patients who underwent echocardiography between 2012 and 2015 at Tel-Aviv Medical Center and had an aortic valve area of ≤1.0 cm2, a mean gradient of <40 mm Hg, a stroke volume index of >35 ml/m2, and symptoms formed the study group. Patients designated for intervention (SAVR or TAVR) had their procedure within 6 months of the echocardiogram; the others were treated conservatively. The endpoints were all-cause mortality and cardiac-related mortality.
RESULTS: During the study period, 1,358 patients with an aortic valve area of ≤1.0 cm2 and symptoms were identified; 34% of these had normal flow and low gradient aortic stenosis and 303 were included. After mean follow-up of 652 days, 60 patients (20%) had died, with overall mortality rates of 28%, 10%, and 12% for conservatively treated, TAVR, and SAVR patients, respectively (p < 0.001). Using Cox regression with adjustment for other variables, TAVR was associated with improved survival versus conservative treatment (hazard ratio [HR]: 0.49; 95% confidence interval [CI]: 0.26 to 0.93; p = 0.03), and lower cardiac mortality (HR: 0.30; 95% CI: 0.10 to 0.74; p = 0.007) with no significant difference for SAVR versus TAVR. After propensity score matching of TAVR and conservatively treated patients, 25 of 94 (28%) conservatively treated and 10 of 94 (12%) TAVR patients had died (p = 0.016). In the matched cohort, Cox regression showed that TAVR had a significant association with improved survival (HR: 0.42; 95% CI: 0.20 to 0.86; p = 0.03).
CONCLUSIONS: Symptomatic patients with an aortic valve area of ≤1.0 cm2, normal flow, and low gradient may benefit from intervention as opposed to conservative treatment.
引用
- Zusman O, Pressman GS, Banai S, et al. Intervention Versus Observation in Symptomatic Patients With Normal Flow Low Gradient Severe Aortic Stenosis. JACC Cardiovasc Imaging. 2017. PMID: 29055632. doi:10.1016/j.jcmg.2017.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。